Management of Elderly Male with CKD Stage 4 and COVID-19

Immediate Assessment and Monitoring Protocol

The American College of Physicians recommends measuring serum urea, creatinine, and electrolytes at minimum every 48 hours, or more frequently if clinically deteriorating, as acute-on-chronic kidney injury dramatically increases mortality risk in CKD patients with COVID-19 1
Track fluid status daily through clinical examination and strict fluid balance monitoring, maintaining optimal hydration to reduce AKI incidence 1
Monitor coagulation parameters closely, particularly D-dimer levels, which are significantly elevated in elderly COVID-19 patients and indicate disseminated intravascular coagulation risk 3, 1
Perform respiratory pathogen surveillance aggressively, as elderly patients demonstrate significantly higher neutrophil ratios and secondary infection susceptibility 3, 2

The National Institute for Health and Care Excellence recommends administering dexamethasone 6 mg daily for 10 days ONLY after oxygen requirement is established, as this reduces all-cause mortality by 3% and decreases mechanical ventilation requirements 1, 2
Reduce dexamethasone dose to 1/2 of standard adult dose (3 mg daily) if patient is over 80 years old, or to 3/4 to 4/5 (4.5-5 mg daily) if 60-80 years, due to deteriorated hepatic and renal clearance 1, 2
Add tocilizumab or sarilumab if IL-6 or CRP ≥100 mg/L in patients on oxygen support, as this reduces mortality particularly at higher CRP levels 1, 2

Systematically reduce ALL medication doses: patients 60-80 years should receive 3/4 to 4/5 of standard adult doses; those over 80 years require 1/2 of adult doses due to deteriorated hepatic and renal clearance 3, 1, 2
Review all prescriptions to minimize polypharmacy and prevent drug-drug interactions 3, 1, 2

Refer for specialist nephrology consultation if any of the following occur: diagnostic uncertainty about AKI cause, abnormal urinalysis suggesting COVID-19-induced kidney damage, complex fluid management needs, AKI worsening despite initial management or not resolved after 48 hours, or usual indications for renal replacement therapy develop 1
Note that 31% of COVID-19 patients on ventilators and 4% not on ventilators require renal replacement therapy 1

Perform respiratory pathogen monitoring actively and initiate targeted anti-infective treatment promptly when indicated, as elderly patients are significantly more susceptible to secondary bacterial infections 3, 1, 2
Monitor neutrophil ratios, which are significantly higher in elderly COVID-19 patients 3

Engage community workers, nurses, pharmacists, physiotherapists, occupational therapists, and mental health providers in collaborative decision-making to address multimorbidity and functional decline 3, 2
Review medication prescriptions collaboratively to reduce polypharmacy 3

Establish treatment escalation plans immediately, as COVID-19 patients may deteriorate rapidly and need urgent hospital admission 4
Discuss risks, benefits, and likely outcomes of treatment options with patient and family when possible 4

For distressing cough, consider short-term use of codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution 4
Be aware that older patients with comorbidities and impaired immunity are more likely to develop severe pneumonia leading to respiratory failure 4